Many drugs come in two forms: expensive branded drugs and cheaper generic copies. Switzerland’s Federal Council hopes a shift to cheaper generic and bio-similar medicines can shave CHF 250 million from Switzerland’s rapidly rising cost of healthcare, reported SRF. New rules on medicine choices and health insurance were already set to come into force on […]
Drugs in Switzerland more expensive than ever compared to Europe
A recent study by Interpharma and Santésuisse shows how rapidly drug prices have risen in Switzerland over the 10 years to 2020. Between 2010 and 2020, medicine prices have risen by nearly 37% in Switzerland. In addition, the cost of basic health insurance has risen at 3 times the rate of GDP over the same […]
Drug spending continues to explode in Switzerland
Last week, the government announced that it had shaved CHF 100 million off the cost of drug purchases from 1 January 2020. This week numbers obtained by RTS from Curafutura, a health insurance association, show drug spending rose CHF 420 million from CHF 6.9 billion to CHF 7 billion between October 2018 and September 2019 […]
